SCHEMBL16211129

SCHEMBL16211129

CC(=O)OC(C)=O.CSC(C)C#N

nearest known ligand 0.46

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.46
ALDH1A1 P00352 1/20 0.46
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL925795 0.80
Ammonia Solution, Strong SCHEMBL28286299 0.74
Acetonitrile SCHEMBL27680478 0.72 ALDH1A1 (0.67) TSHRALDH1A1HSD17B10TDP1
Acetonitrile SCHEMBL4869057 0.72 ALDH1A1 (0.67) TSHRALDH1A1HSD17B10TDP1
Ammonia Solution, Strong SCHEMBL27368013 0.71 ALDH1A1 (0.91) TSHRALDH1A1HSD17B10TDP1
Ammonia Solution, Strong SCHEMBL27486713 0.71
Water SCHEMBL8957849 0.71
Water SCHEMBL18836927 0.71
Water SCHEMBL27804318 0.71 ALDH1A1 (0.91) TSHRALDH1A1HSD17B10TDP1
Ammonia Solution, Strong SCHEMBL7931716 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9024056-B2 Crystalline form of 3-methylsulfonylpropionitrile OLATEC INDUSTRIES LLC (US) 2015-05-05 US disclosed
US-20140330037-A1 CRYSTALLINE FORM OF 3-METHYLSULFONYLPROPIONITRILE OLATEC THERAPEUTICS, INC. 2014-11-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140330037-A1 CRYSTALLINE FORM OF 3-METHYLSULFONYLPROPIONITRILE SFN, SF3B1, SF3B2 TSHR 4664/4885ALDH1A1 3453/4885HSD17B10 3402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.